THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
- 18/12/2014 : RT @eupatients: SAVE THE DATE@eupatients launches the second round of applications for #EUPATI #Patient #Expert course on Medicines dev on …
- 18/12/2014 : Want to know more about #IMI2 rules and procedures? Register for our webinar on 9 January at 14:00 CET http://t.co/M8fNP9XkXd
- 17/12/2014 : #IMI2 Call 3 includes a topic on #pertussis / #WhoopingCough #vaccines where IMI will work with @gatesfoundation http://t.co/wmN3MPyhkB